Early Diagnostic Markers of Late-Onset Neonatal Sepsis.
early diagnosis
endocan
inflammatory markers
interleukins
neonatal sepsis
procalcitonin
Journal
Pediatric reports
ISSN: 2036-749X
Titre abrégé: Pediatr Rep
Pays: Switzerland
ID NLM: 101551542
Informations de publication
Date de publication:
20 Sep 2023
20 Sep 2023
Historique:
received:
16
08
2023
revised:
11
09
2023
accepted:
14
09
2023
medline:
27
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
Early diagnosis of nosocomial infections in newborns is a great challenge, because in the initial phase of systemic infection, clinical symptoms are often non-specific, and routinely used hematological markers are not sufficiently informative. The aim of this study was to determine the potential of early inflammatory markers to diagnose late-onset neonatal sepsis-procalcitonin (PCT), interleukin 6 (IL-6), interleukin 8 (IL-8) and endocan (ESM-1). A prospective clinical-epidemiological study was conducted in a third-level NICU in Pleven, Bulgaria. Patients with suspected late-onset sepsis and healthy controls were tested. A sandwich ELISA method was used to measure the serum concentrations of biomarkers. Sixty newborns were included, of which 35% symptomatic and infected, 33.3% symptomatic but uninfected and 31.7% asymptomatic controls. The mean values of PCT, IL-6, I/T index and PLT differ significantly in the three groups. For ESM-1, IL-8 and CRP, the difference was statistically insignificant. The best sensitivity (78%) and negative predictive value (84%) was found for IL-6. The combinations of PCT + IL-6 and PCT + IL-6+ I/T+ PLT showed very good diagnostic potential. The introduction into the routine practice of indicators such as PCT and IL-6 may provide an opportunity to promptly optimize the diagnostic and therapeutic approach to LOS.
Identifiants
pubmed: 37755410
pii: pediatric15030050
doi: 10.3390/pediatric15030050
pmc: PMC10535522
doi:
Types de publication
Journal Article
Langues
eng
Pagination
548-559Subventions
Organisme : Medical University Pleven
ID : D3/2022
Références
J Vasc Res. 2000 Sep-Oct;37(5):417-25
pubmed: 11025405
Pediatr Neonatol. 2018 Aug;59(4):329-338
pubmed: 29239828
Cureus. 2022 Mar 16;14(3):e23215
pubmed: 35449688
BMC Pediatr. 2022 Jul 13;22(1):411
pubmed: 35831816
Indian J Pharmacol. 2014 Nov-Dec;46(6):579-83
pubmed: 25538326
Children (Basel). 2020 Dec 20;7(12):
pubmed: 33419284
Cureus. 2021 Aug 10;13(8):e17065
pubmed: 34522543
Sisli Etfal Hastan Tip Bul. 2020 Jun 12;54(2):142-158
pubmed: 32617051
Virulence. 2014 Jan 1;5(1):170-8
pubmed: 24185532
J Trop Pediatr. 2005 Dec;51(6):388-91
pubmed: 16126807
Front Pediatr. 2022 Mar 23;10:840778
pubmed: 35402358
Rev Chilena Infectol. 2012 Oct;29(5):511-6
pubmed: 23282492
J Perinatol. 2019 Jul;39(7):893-903
pubmed: 30926891
J Matern Fetal Neonatal Med. 2018 Jun;31(12):1646-1659
pubmed: 28427289
Neonatology. 2019;116(1):42-51
pubmed: 30947195
Clin Perinatol. 2021 Jun;48(2):215-227
pubmed: 34030810
Arch Dis Child Fetal Neonatal Ed. 1997 Nov;77(3):F221-7
pubmed: 9462194
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F257-63
pubmed: 25425653
Curr Opin Pediatr. 2016 Apr;28(2):135-40
pubmed: 26766602
Clin Perinatol. 2010 Sep;37(3):599-610
pubmed: 20813273
Iran J Pediatr. 2010 Mar;20(1):41-7
pubmed: 23056680
Jt Comm J Qual Patient Saf. 2016 May;42(5):232-9
pubmed: 27066927
Pediatr Infect Dis J. 2012 Aug;31(8):803-7
pubmed: 22531232
Eur J Pediatr. 2013 Apr;172(4):501-8
pubmed: 23271492
Microorganisms. 2023 Jan 17;11(2):
pubmed: 36838200